| Two thousand consecutive pancreaticoduodenectomies JL Cameron, J He Journal of the American College of Surgeons 220 (4), 530-536, 2015 | 666 | 2015 |
| Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma VP Groot, N Rezaee, W Wu, JL Cameron, EK Fishman, RH Hruban, ... Annals of surgery 267 (5), 936-945, 2018 | 594 | 2018 |
| Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers JD Cohen, AA Javed, C Thoburn, F Wong, J Tie, P Gibbs, CM Schmidt, ... Proceedings of the National Academy of Sciences 114 (38), 10202-10207, 2017 | 560 | 2017 |
| Multi-institutional validation study of the American Joint Commission on Cancer changes for T and N staging in patients with pancreatic adenocarcinoma PJ Allen, D Kuk, C Fernandez-del Castillo, O Basturk, CL Wolfgang, ... Annals of surgery 265 (1), 185-191, 2017 | 503 | 2017 |
| Deleterious germline mutations in patients with apparently sporadic pancreatic adenocarcinoma K Shindo, J Yu, M Suenaga, S Fesharakizadeh, C Cho, A Macgregor-Das, ... Journal of Clinical Oncology 35 (30), 3382-3390, 2017 | 437 | 2017 |
| Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology MH Shah, WS Goldner, AB Benson, E Bergsland, LS Blaszkowsky, ... Journal of the National Comprehensive Cancer Network 19 (7), 839-868, 2021 | 391 | 2021 |
| Survival in locally advanced pancreatic cancer after neoadjuvant therapy and surgical resection G Gemenetzis, VP Groot, AB Blair, DA Laheru, L Zheng, AK Narang, ... Annals of surgery 270 (2), 340-347, 2019 | 384 | 2019 |
| 2564 resected periampullary adenocarcinomas at a single institution: trends over three decades J He, N Ahuja, MA Makary, JL Cameron, FE Eckhauser, MA Choti, ... HPB 16 (1), 83-90, 2014 | 352 | 2014 |
| NCCN guidelines insights: neuroendocrine and adrenal tumors, version 2.2018 MH Shah, WS Goldner, TR Halfdanarson, E Bergsland, JD Berlin, ... Journal of the National Comprehensive Cancer Network 16 (6), 693-702, 2018 | 350 | 2018 |
| Defining and predicting early recurrence in 957 patients with resected pancreatic ductal adenocarcinoma VP Groot, G Gemenetzis, AB Blair, RJ Rivero-Soto, J Yu, AA Javed, ... Annals of surgery 269 (6), 1154-1162, 2019 | 303 | 2019 |
| The impact of postoperative complications on the administration of adjuvant therapy following pancreaticoduodenectomy for adenocarcinoma W Wu, J He, JL Cameron, M Makary, K Soares, N Ahuja, N Rezaee, ... Annals of surgical oncology 21, 2873-2881, 2014 | 211 | 2014 |
| Association of BRAF mutations with survival and recurrence in surgically treated patients with metastatic colorectal liver cancer GA Margonis, S Buettner, N Andreatos, Y Kim, D Wagner, K Sasaki, ... JAMA surgery 153 (7), e180996-e180996, 2018 | 210 | 2018 |
| Long-term outcomes with ileal pouch-anal anastomosis and Crohn's disease: pouch retention and implications of delayed diagnosis GB Melton, VW Fazio, RP Kiran, J He, IC Lavery, B Shen, JP Achkar, ... Annals of surgery 248 (4), 608-616, 2008 | 205 | 2008 |
| Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneity L Li, H Knutsdottir, K Hui, MJ Weiss, J He, B Philosophe, AM Cameron, ... JCI insight 4 (2), 2019 | 201 | 2019 |
| International consensus statement on robotic hepatectomy surgery in 2018 R Liu, G Wakabayashi, HJ Kim, GH Choi, A Yiengpruksawan, Y Fong, ... World journal of gastroenterology 25 (12), 1432, 2019 | 196 | 2019 |
| Antitumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice S Ran, J He, X Huang, M Soares, D Scothorn, PE Thorpe Clinical cancer research 11 (4), 1551-1562, 2005 | 190 | 2005 |
| Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm? J He, JL Cameron, N Ahuja, MA Makary, K Hirose, MA Choti, RD Schulick, ... Journal of the American College of Surgeons 216 (4), 657-665, 2013 | 174 | 2013 |
| Is a pathological complete response following neoadjuvant chemoradiation associated with prolonged survival in patients with pancreatic cancer? J He, AB Blair, VP Groot, AA Javed, RA Burkhart, G Gemenetzis, ... Annals of surgery 268 (1), 1-8, 2018 | 173 | 2018 |
| Neoadjuvant Cabozantinib and Nivolumab Converts Locally Advanced HCC into Resectable Disease with Enhanced Antitumor Immunity. WJ Ho, Q Zhu, J Durham, A Popovic, S Xavier, J Leatherman, A Mohan, ... Nature cancer 2 (9), 891-903, 2021 | 165 | 2021 |
| Circulating tumor DNA as a clinical test in resected pancreatic cancer VP Groot, S Mosier, AA Javed, JA Teinor, G Gemenetzis, D Ding, ... Clinical Cancer Research 25 (16), 4973-4984, 2019 | 161 | 2019 |
Christopher L.WolfgangNYU Grossman School of MedicineAdresse e-mail validée de NYULangone.org
